(Part 7 of 9) Ann Tsukamoto, Ph.D., spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Tsukamoto is the Chief Operating Officer at Stem Cells, Inc., a Palo Alto based company that has begun a stem cell based human clinical trial for the treatment of Batten disease.
More:
Getting Stem Cell Therapies Approved: Ann Tsukamoto - CIRM Science Writer's Seminar - Video